-
Loading metrics
ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML Therapy
- Clara I. Aceves-Luquero,
- Anupriya Agarwal,
- Juan L. Callejas-Valera,
- Laura Arias-González,
- Azucena Esparís-Ogando,
- Luis del Peso Ovalle,
- Itxaso Bellón-Echeverria,
- Miguel A. de la Cruz-Morcillo,
- Eva M. Galán Moya,
- Inmaculada Moreno Gimeno
x
- Published: July 1, 2009
- https://doi.org/10.1371/journal.pone.0006124